Gastroenterology Practice Questions

Q: A 41-year-old male patient presented with recurrent episodes of bloody diarrhea for 5 years. Despite regular treatment with adequate doses of sulfasalazine, he has had several exacerbations of his disease and required several weeks of steroids for the control of flares. What should be the next line of treatment for him?

Azathioprine. ### Explanation The patient presents with chronic, relapsing **Ulcerative Colitis (UC)** that is **steroid-dependent**. He has failed maintenance therapy with 5-ASA (Sulfasalazine) and requires repeated courses of corticosteroids to control flares. [1] **1. Why Azathioprine is Correct:** In inflammatory bowel disease (IBD), when a patient cannot taper off steroids without a relapse or requires frequent steroid pulses, they are classified as "steroid-dependent." The standard next step in management is the introduction of **Thiopurines (Azathioprine or 6-Mercaptopurine)**. These are "steroid-sparing agents" used for the maintenance of remission in UC. [1] They take 3–6 months to reach peak efficacy, making them unsuitable for acute flares but ideal for long-term control in this scenario. **2. Why Other Options are Incorrect:** * **A. Methotrexate:** While used as a second-line immunomodulator in **Crohn’s Disease**, its efficacy in Ulcerative Colitis is not well-established and is generally not the first-choice steroid-sparing agent for UC. * **C. Cyclosporine:** This is a potent immunosuppressant used for **acute severe ulcerative colitis** (refractory to IV steroids) as "rescue therapy" to avoid emergency colectomy. It is not used for routine maintenance in a stable but steroid-dependent patient. * **D. Cyclophosphamide:** This drug has no established role in the standard management of Ulcerative Colitis due to its significant toxicity profile. **Clinical Pearls for NEET-PG:** * **Step-up Therapy:** 5-ASA → Steroids (for induction) → Thiopurines (for maintenance) → Biologics (Infliximab/Adalimumab) → Surgery. [1] * **Monitoring:** Before starting Azathioprine, check **TPMT (Thiopurine Methyltransferase)** activity to predict the risk of severe bone marrow suppression. * **Side Effects:** Monitor for pancreatitis, leucopenia, and increased risk of non-melanoma skin cancer/lymphoma.

Q: Which of the following is NOT a precipitating factor of hepatic encephalopathy in a patient with chronic liver disease?

Hyperkalemia. Hepatic Encephalopathy (HE) is a reversible neuropsychiatric syndrome caused by the accumulation of neurotoxins (primarily ammonia) in the brain due to liver failure or portosystemic shunting [1]. **Why Hyperkalemia is the Correct Answer:** **Hypokalemia**, not hyperkalemia, is a classic precipitant of HE. When potassium levels are low, the body attempts to conserve $K^+$ in the renal tubules by exchanging it for $H^+$ ions. This intracellular acidosis in renal cells stimulates the enzyme glutaminase, leading to increased **renal ammoniagenesis** (production of $NH_3$). Furthermore, hypokalemia-induced alkalosis shifts the equilibrium from ammonium ($NH_4^+$) to ammonia ($NH_3$), which easily crosses the blood-brain barrier. **Analysis of Incorrect Options:** * **TIPS:** This procedure creates a low-resistance tract between the portal and systemic circulation [1]. By bypassing the liver's detoxification process, neurotoxins reach the systemic circulation directly, making HE a common post-procedural complication. * **High Dietary Protein:** Protein breakdown by colonic bacteria produces ammonia [1]. A sudden large protein load (or GI bleed, which is essentially a protein load) increases ammonia production beyond the liver's capacity to clear it. * **Infection:** Sepsis and spontaneous bacterial peritonitis (SBP) increase tissue catabolism and impair renal function, both of which elevate blood ammonia levels and increase the permeability of the blood-brain barrier. **High-Yield Clinical Pearls for NEET-PG:** * **Most common precipitant:** Azotemia (often due to over-diuresis) and Infections. * **Electrolyte disturbances:** Hypokalemia, Hyponatremia, and Metabolic Alkalosis all precipitate HE. * **Drug of choice:** **Lactulose** (converts $NH_3$ to non-absorbable $NH_4^+$ and acts as an osmotic laxative). * **Second-line/Add-on:** **Rifaximin** (non-absorbable antibiotic that reduces ammonia-producing gut flora).

Q: Hereditary pancreatitis is characterized by all except:

Autosomal recessive inheritance. Hereditary pancreatitis is a rare genetic disorder characterized by recurrent episodes of acute pancreatitis starting in childhood, often progressing to chronic pancreatitis. **1. Why Option B is the correct answer (The Exception):** Hereditary pancreatitis follows an **Autosomal Dominant** inheritance pattern, not autosomal recessive. It is primarily caused by mutations in the **PRSS1 gene**, which encodes for cationic trypsinogen. Because it is dominant, a single copy of the mutated gene from one parent is sufficient to cause the disease. **2. Analysis of other options:** * **Option A:** Unlike alcoholic pancreatitis, which shows a male predominance, hereditary pancreatitis affects **males and females equally**. * **Option C:** The PRSS1 gene is located on the **long arm of chromosome 7 (7q35)**. The most common mutation is **R122H**, which prevents the deactivation of trypsin, leading to premature intrapancreatic enzyme activation and autodigestion. * **Option D:** The disease exhibits incomplete penetrance, generally accepted to be approximately **80%** [1]. This means 20% of individuals carrying the mutation may never develop clinical symptoms. **Clinical Pearls for NEET-PG:** * **Triad of Risk:** Patients have a significantly increased risk (up to 40-50 fold) of developing **Pancreatic Adenocarcinoma**, especially if they smoke. * **Early Onset:** Symptoms typically begin before age 20 (often before age 10). * **Other Genes:** While PRSS1 is the most common, mutations in **SPINK1** (Serine protease inhibitor Kazal-type 1) and **CFTR** are also associated with idiopathic/hereditary chronic pancreatitis [2]. * **Management:** Focuses on pain control, pancreatic enzyme replacement therapy (PERT), and screening for diabetes and malignancy.

Q: Oral ulceration resembling aphthae are encountered in which of the following conditions?

Gluten enteropathy. **Explanation:** **1. Why Gluten Enteropathy is Correct:** Gluten enteropathy (Celiac Disease) is a common systemic cause of recurrent aphthous-like ulcers. These oral lesions often precede gastrointestinal symptoms. The underlying mechanism is two-fold: first, the **malabsorption** of essential nutrients (specifically Iron, Vitamin B12, and Folate) due to villous atrophy in the small intestine; and second, an **immunological cross-reactivity** where the oral mucosa becomes a target of the inflammatory process. In many patients, a gluten-free diet leads to the complete resolution of these ulcers. **2. Why the Other Options are Incorrect:** * **Chronic Smokers:** Interestingly, smoking is considered "protective" against aphthous ulcers. Nicotine stimulates the production of adrenal steroids and increases keratinization of the oral mucosa, making it less susceptible to ulceration. Ulcers often flare up *after* smoking cessation. * **Excess of B-complex vitamins:** It is the **deficiency** (specifically B1, B2, B6, and B12), not the excess, that causes oral manifestations like glossitis, cheilosis, and aphthous ulcers. * **Anti-malarial medication:** While some drugs (like NSAIDs or Nicorandil) cause oral ulcers, anti-malarials (e.g., Hydroxychloroquine) are actually sometimes used off-label to *treat* severe recurrent aphthous stomatitis due to their immunomodulatory effects. **Clinical Pearls for NEET-PG:** * **RAS (Recurrent Aphthous Stomatitis)** is also strongly associated with **Behçet’s Disease** (pustular/genital sores) and **IBD** (Crohn’s > UC). * **Dermatitis Herpetiformis** is the pathognomonic skin manifestation of Celiac disease. * **Screening Gold Standard:** IgA Anti-tissue Transglutaminase (tTG) antibodies.

Q: A 40-year-old male presents with hematemesis. On examination, his BP was 90/60 mmHg and heart rate was 120/min. Splenomegaly was also present. What is the most probable cause of his bleeding?

Portal hypertension. ### Explanation The clinical presentation of **hematemesis** associated with **splenomegaly** and signs of **hemodynamic instability** (hypotension and tachycardia) strongly points toward **Portal Hypertension**, most commonly due to liver cirrhosis or non-cirrhotic portal fibrosis [1]. **1. Why Portal Hypertension is correct:** In portal hypertension, the increased pressure in the portal venous system leads to the development of portosystemic collaterals [2]. The most clinically significant collaterals are **esophageal and gastric varices**, which are prone to rupture, causing massive, life-threatening hematemesis [2]. The presence of **splenomegaly** is a hallmark sign of portal hypertension, resulting from chronic passive congestion of the spleen (congestive splenomegaly) [1]. **2. Why the other options are incorrect:** * **Gastric and Duodenal Ulcers (Options B & C):** While Peptic Ulcer Disease (PUD) is the most common cause of upper GI bleeding overall, it does **not** cause splenomegaly [1]. The presence of an enlarged spleen specifically shifts the differential toward portal venous pathology. * **Drug-induced GI injury (Option D):** NSAIDs or steroids can cause erosive gastritis or ulcers leading to hematemesis, but like PUD, they do not account for the finding of splenomegaly [1]. **Clinical Pearls for NEET-PG:** * **Most common cause of Portal HTN in India:** Liver Cirrhosis (Alcoholic/Viral). * **Most common cause of massive hematemesis in children with splenomegaly:** Extrahepatic Portal Venous Obstruction (EHPVO). * **Management Priority:** In a patient with BP 90/60 and HR 120, the immediate priority is **hemodynamic stabilization** (IV fluids/blood) before diagnostic endoscopy [1]. * **Drug of choice for active variceal bleed:** Terlipressin or Octreotide. * **Definitive treatment for acute variceal bleed:** Endoscopic Variceal Ligation (EVL).

Q: A 40-year-old woman presents with a 2-month history of burning epigastric pain that usually occurs between meals. The pain can be relieved with antacids or food. The patient also reports a recent history of tarry stools. She denies taking aspirin or NSAIDs. Laboratory studies show a microcytic, hypochromic anemia (serum hemoglobin = 8.5 g/dL). Gastroscopy reveals a bleeding mucosal defect in the antrum measuring 1.5 cm in diameter. An endoscopic biopsy shows that the lesion lacks mucosal lining cells and is composed of amorphous, cellular debris and numerous neutrophils. Which of the following is the most important factor in the pathogenesis of this patient's disease?

Helicobacter pylori infection. The clinical presentation of epigastric pain relieved by food/antacids, combined with melena (tarry stools) and microcytic anemia, is classic for **Peptic Ulcer Disease (PUD)**. The gastroscopy finding of a 1.5 cm mucosal defect in the antrum confirms a gastric ulcer. **1. Why H. pylori is correct:** *Helicobacter pylori* is the most important etiological factor for PUD worldwide, accounting for approximately 70% of gastric ulcers and over 90% of duodenal ulcers. In the absence of NSAID use (as specified in the prompt), *H. pylori* is the most likely cause [1]. It induces chronic inflammation by secreting urease and cytotoxins (CagA, VacA), which break down the protective mucosal barrier, allowing gastric acid to cause autodigestion and ulceration [1]. **2. Why other options are incorrect:** * **Achlorhydria:** This is the absence of gastric acid. PUD requires the presence of acid ("No acid, no ulcer"). Achlorhydria is associated with Pernicious Anemia and Gastric Adenocarcinoma, not PUD. * **Acute Ischemia:** This typically causes "stress ulcers" (e.g., Curling’s or Cushing’s ulcers) in patients with severe trauma, burns, or shock [1]. It presents acutely rather than over a 2-month period. * **Autoimmunity:** Autoimmune gastritis involves antibodies against parietal cells/intrinsic factor [1]. It leads to mucosal atrophy and Vitamin B12 deficiency (Megaloblastic anemia), not localized peptic ulceration. **High-Yield NEET-PG Pearls:** * **Most common site for H. pylori:** Gastric Antrum [1]. * **Gold standard for diagnosis:** Endoscopic biopsy followed by Rapid Urease Test (RUT) or Histopathology (Warthin-Starry stain). * **Non-invasive test of choice:** Urea Breath Test (used for confirming eradication). * **Complications:** Bleeding (most common), Perforation (most common in anterior ulcers), and Gastric Outlet Obstruction.

Q: A false positive D-xylose test is seen in which of the following conditions?

Blind loop syndrome. The **D-xylose test** is used to differentiate between malabsorption caused by intestinal mucosal disease (e.g., Celiac disease) and malabsorption due to pancreatic insufficiency. D-xylose is a pentose sugar that is absorbed in the proximal small intestine via passive diffusion and does not require pancreatic enzymes. **1. Why Blind Loop Syndrome is the Correct Answer:** In **Blind Loop Syndrome** (Small Intestinal Bacterial Overgrowth - SIBO), there is an overgrowth of bacteria in the small bowel [1]. These bacteria metabolize and consume the D-xylose before the intestinal mucosa can absorb it. This results in low urinary excretion of D-xylose, mimicking a mucosal disease pattern [2]. Therefore, it is considered a **false positive** result because the intestinal mucosa itself is actually intact. **2. Analysis of Incorrect Options:** * **Ascites:** This can lead to a **false positive** result. D-xylose is distributed into the ascitic fluid, delaying its excretion in the urine. * **Renal Failure:** This causes a **false positive** result. Since D-xylose is excreted by the kidneys, impaired renal function leads to low urinary levels despite normal intestinal absorption. * **Antibiotic Therapy:** This would actually lead to a **false negative** (or normalization) of the test in a patient with SIBO, as the antibiotics kill the bacteria that were consuming the sugar. **High-Yield Clinical Pearls for NEET-PG:** * **Normal Test:** >4g excreted in urine over 5 hours (after a 25g oral dose). * **Low D-xylose (Positive):** Celiac disease, Tropical sprue, Whipple’s disease, SIBO, and Giardiasis. * **Normal D-xylose in Malabsorption:** Pancreatic insufficiency (e.g., Chronic pancreatitis) because enzyme secretion is not required for D-xylose absorption. * **False Positives (Low urine levels despite normal mucosa):** SIBO, Renal failure, Ascites, and Elderly age (decreased GFR).

Question 1

A 41-year-old male patient presented with recurrent episodes of bloody diarrhea for 5 years. Despite regular treatment with adequate doses of sulfasalazine, he has had several exacerbations of his disease and required several weeks of steroids for the control of flares. What should be the next line of treatment for him?

Accepted Answer

Azathioprine

Answer

Methotrexate

Answer

Cyclosporine

Answer

Cyclophosphamide

Question 2

Which of the following is NOT a precipitating factor of hepatic encephalopathy in a patient with chronic liver disease?

Accepted Answer

Hyperkalemia

Answer

TIPS (Transjugular Intrahepatic Portosystemic Shunt)

Answer

High dietary protein load

Answer

Infection

Question 3

Hereditary pancreatitis is characterized by all except:

Accepted Answer

Autosomal recessive inheritance

Answer

Equal prevalence in males and females

Answer

Mutation of trypsinogen gene on long arm of chromosome 7

Answer

Penetrance is generally accepted to be approximately 80%

Question 4

Oral ulceration resembling aphthae are encountered in which of the following conditions?

Accepted Answer

Gluten enteropathy

Answer

Chronic smokers

Answer

Excess of B-complex vitamins

Answer

Anti-malarial medication

Question 5

A 40-year-old male presents with hematemesis. On examination, his BP was 90/60 mmHg and heart rate was 120/min. Splenomegaly was also present. What is the most probable cause of his bleeding?

Accepted Answer

Portal hypertension

Answer

Gastric ulcer

Answer

Duodenal ulcer

Answer

Drug-induced GI injury

Question 6

A 56-year-old man presents with jaundice and mild fatigue over the past 2 months. He is not on any medications and has no significant past medical history. Physical examination reveals scleral icterus. Laboratory findings include: SGOT: 0.58 microkat/L, SGPT: 0.58 microkat/L, Total bilirubin: 91.7 micromol/L, Direct bilirubin: 85.5 micromol/L, and Alkaline phosphatase: 12 microkat/L. What is the next appropriate diagnostic step?

Accepted Answer

Ultrasound

Answer

Liver biopsy

Answer

Review of peripheral blood smear

Answer

Endoscopic retrograde cholangiopancreatography (ERCP)

Question 7

A 40-year-old woman presents with a 2-month history of burning epigastric pain that usually occurs between meals. The pain can be relieved with antacids or food. The patient also reports a recent history of tarry stools. She denies taking aspirin or NSAIDs. Laboratory studies show a microcytic, hypochromic anemia (serum hemoglobin = 8.5 g/dL). Gastroscopy reveals a bleeding mucosal defect in the antrum measuring 1.5 cm in diameter. An endoscopic biopsy shows that the lesion lacks mucosal lining cells and is composed of amorphous, cellular debris and numerous neutrophils. Which of the following is the most important factor in the pathogenesis of this patient's disease?

Accepted Answer

Helicobacter pylori infection

Answer

Achlorhydria

Answer

Acute ischemia

Answer

Autoimmunity

Question 8

What is the drug of choice in the treatment of tropical sprue?

Accepted Answer

Tetracycline

Answer

Prednisolone

Answer

Gliadin

Answer

Cyclosporine

Question 9

A patient with chronic liver disease presents with ascites and has no history of bleeding varices. The patient develops hematemesis and melena. What is the next step in management?

Accepted Answer

Fresh frozen plasma transfusion

Answer

Injectable vitamin K

Answer

Injectable Tranexamic acid

Answer

Platelet transfusion

Question 10

A false positive D-xylose test is seen in which of the following conditions?

Accepted Answer

Blind loop syndrome

Answer

Ascites

Answer

Renal failure

Answer

Antibiotic therapy

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?